BioSpace News Archive

Wilmington, Delaware, United States: Presently, a number of health problems related to stomach such as ulcer, liver, intestinal pain and cancer, and skin related problems are rising rapidly.

Basilea Pharmaceutica Ltd. announced that its license partner, Pfizer Inc., has received a Drug Approval License from the National Medical Products Administration in China, for the intravenous formulation of Cresemba® for the treatment of adult patients with invasive aspergillosis and invasive mucormycosis.

Kinarus Therapeutics Holding AG announced that it will host a key opinion leader event for investors in Zurich on Monday, June 27, starting at 12:15 pm CET.

Endoscopy ultrasound market is projected to expand substantially at a CAGR of 5.7% during the forecast period.

Telemedicine, the future of healthcare services, refers to offering assistance to patients from a distance.

Wilmington, Delaware, United States: An autoimmune disorder that affects the skin and internal organs is called systemic scleroderma.

Wilmington, Delaware, United States: Transparency Market Research has published a new report titled, “Surgical Robots Market”.

Fact.MR – A Market Research and Competitive Intelligence Provider: Demand for osteoporosis therapeutics is anticipated to increase at a CAGR of 2.9% from 2022 to 2026, as per this new analysis by Fact.MR, a market research and competitive intelligence provider.

Fact.MR – A Market Research and Competitive Intelligence Provider: Demand for medical device technologies was valued at US$ 470.32 Billion in 2021, and is likely to flourish at a Y-o-Y expansion rate of 4.6% in 2022, reaching US$ 491.95 Billion.

Sensorion is pleased to announce the participation of CEO Nawal Ouzren in the LifeSci Partners 2nd Annual Genetic Medicines Symposium being held virtually on June 28-29, 2022.